Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 601–700 of 1,011
Rahimian, R., Masih‐Khan, E., Lo, M., van Breemen, C., McManus, B. M., & Dubé, G. P. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011927113563 · Cited by 127
Berthou, L., Saladin, R., Yaqoob, P., Branellec, D., Calder, P., Fruchart, J., Denèfle, P., Auwerx, J., & Staels, B. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20797.x · Cited by 119
Lipid Metabolism Alteration by Endocrine Disruptors in Animal Models: An Overview
Maradonna, F., & Carnevali, O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00654 · Cited by 124
“In the last decades, the study of a group of xenobiotic compounds known as peroxisome proliferators has led to the discovery of peroxisome proliferator-activated receptors (PPARs) as a novel subfamily of nuclear receptors (NRs) (8).”
BackgroundPPARs Mediate Lipid Signaling in Inflammation and Cancer
Michalik, L., & Wahli, W. (2008) · PPAR Research · doi:10.1155/2008/134059 · Cited by 117
“[6] I.”
BackgroundSertznig, P., Seifert, M., Tilgen, W., & Reichrath, J. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20998 · Cited by 121
“PPARa Murine PPARa was the first member of this nuclear receptor subclass to be cloned (Issemann and Green, 1990).”
BackgroundRetnakaran, R. (1994) · Molecular Endocrinology · doi:10.1210/me.8.9.1234 · Cited by 116
Haubenwallner, S., Essenburg, A. D., Barnett, B. C., Pape, M. E., DeMattos, R. B., Krause, B. R., Minton, L. L., Auerbach, B. J., Newton, R. S., & Leff, T. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41090-9 · Cited by 119
Miyata, K. S., McCaw, S. E., Patel, H. V., Rachubinski, R. A., & Capone, J. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9189 · Cited by 116
Current and potential treatments for primary biliary cholangitis
Shah, R. A., & Kowdley, K. V. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30343-7 · Cited by 115
Expression of peroxisome proliferator‐activated receptor (PPAR) in human prostate cancer
Segawa, Y., Yoshimura, R., Hase, T., Nakatani, T., Wada, S., Kawahito, Y., Kishimoto, T., & Sano, H. (2002) · The Prostate · doi:10.1002/pros.10058 · Cited by 117
“factors, which include steroid hormone, vitamin D3, retinoid, and thyroid hormone receptors [26].”
BackgroundGuo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 129
AMPK-Dependent Metabolic Regulation by PPAR Agonists
Lee, W. H., & Kim, S. G. (2010) · PPAR Research · doi:10.1155/2010/549101 · Cited by 127
“Hindawi Publishing Corporation PPAR Research Volume 2010, Article ID 549101, 10 pages doi:10.1155/2010/549101”
BackgroundInfluentialPeters, J. M., Hollingshead, H. E., & Gonzalez, F. J. (2008) · Clinical Science · doi:10.1042/cs20080022 · Cited by 111
“The seminal work identifying PPARα (peroxisome-proliferator-activated receptor α) in 1990 [1] led to the subsequent identification of a family of three related receptors in the nuclear receptor superfamily that can modulate biological function by acting as transcription factors or through protein-protein interactions.”
MethodPolyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors
Bordoni, A., Nunzio, M. D., Danesi, F., & Biagi, P. L. (2006) · Genes & Nutrition · doi:10.1007/bf02829951 · Cited by 130
“INSIDE THE NUCLEUS: PEROXISOMEPROLIFERATOR ACTIVATED RECEPTORS (PPARs) In 1990 PPARs were identified as transcription factors (Issemann and Green, 1990), and in 1992 Gottilicher et al. (Gottilicher et al., 1992) demonstrated that linoleic and arachidonic acid potently activate them.”
MethodHuang, J., Jia, Y., Fu, T., Viswakarma, N., Bai, L., Rao, M. S., Zhu, Y., Borensztajn, J., & Reddy, J. K. (2012) · The FASEB Journal · doi:10.1096/fj.11-194019 · Cited by 117
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Lee, T.-W., Bai, K.-J., Lee, T.-I., Chao, T.-F., Kao, Y.-H., & Chen, Y.-J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0309-5 · Cited by 110
“PPAR-α was first cloned in 1990 and so named because it was activated by the lipid-lowering drug, fibrate, which causes hepatic peroxisome proliferation in rodents [38].”
BackgroundThe ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders
Cullingford, T. E. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.008 · Cited by 124
“In the early 1990s, the hepatic fatty acid ‘hormone’ receptor was identified as the peroxisome proliferator-activated receptor a (PPARa) [14].”
BackgroundKambia, K., Dine, T., Azar, R., Gressier, B., Luyckx, M., & Brunet, C. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00840-7 · Cited by 121
Crabb, D. W., & Liangpunsakul, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04582.x · Cited by 122
Transcriptional coactivator PGC-1α promotes peroxisomal remodeling and biogenesis
Bagattin, A., Hugendubler, L., & Mueller, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009176107 · Cited by 111
“The nuclear receptor PPARα plays a pivotal role in regulating hepatic peroxisomal proliferation (18, 19), therefore we wished to examine whether PGC-1α influenced the peroxisomal compartment through this pathway.”
BackgroundInoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 123
Finstad, H. S., Kolset, S. O., Holme, J. A., Wiger, R., Farrants, A. Ö., Blomhoff, R., & Drevon, C. A. (1994) · Blood · doi:10.1182/blood.v84.11.3799.bloodjournal84113799 · Cited by 116
Reig, A., Sesé, P., & Parés, A. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.287 · Cited by 115
PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases
de Carvalho, M. V., Gonçalves-de-Albuquerque, C. F., & Silva, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020805 · Cited by 120
“PPARα (also called NR1C1) was initially identified as an orphan receptor activated by various peroxisome proliferators [3].”
BackgroundVitamin A regulation of gene expression: molecular mechanism of a prototype gene
McGrane, M. M. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.10.006 · Cited by 130
“The classical peroxisome proliferator-inducible pathway, that of peroxisomal h-oxidation [95–97], utilizes very long fatty acids as substrates, and these very long chain fatty acids, in turn, are the naturally occurring ligands of PPARa, the predominant receptor isoform in liver [92].”
BackgroundMethodOGATA, T., MIYAUCHI, T., SAKAI, S., IRUKAYAMA-TOMOBE, Y., GOTO, K., & YAMAGUCHI, I. (2002) · Clinical Science · doi:10.1042/cs103s284s · Cited by 116
Ppars, metabolic disease and atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0871 · Cited by 129
Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C., & Rossi, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6232 · Cited by 131
“The metabolites of PGD2, (12)PGJ2 and 15dPGJ2, have been shown to activate intracellular peroxisome proliferator-activated receptors (PPARs) which are transducer proteins belonging to the steroid/thyroid/retinoid receptor superfamily that regulate target genes by binding to PPAR response elements (24, 25).”
BackgroundParsing the Role of PPARs in Macrophage Processes
Toobian, D., Ghosh, P., & Katkar, G. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783780 · Cited by 120
“In 1990, Issemann and Green cloned these receptors for the first time and demonstrated that hepatocarcinogens promote the proliferation of peroxisomes in rodents through these receptors, and thus named them Peroxisome Proliferator Activated Receptors (PPARs) (9).”
BackgroundJia, Y., Qi, C., Kashireddi, P., Surapureddi, S., Zhu, Y.-J., Rao, M. S., Le Roith, D., Chambon, P., Gonzalez, F. J., & Reddy, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402391200 · Cited by 111
Mori, T., Kondo, H., Hase, T., Tokimitsu, I., & Murase, T. (2007) · Journal of Nutrition · doi:10.1093/jn/137.12.2629 · Cited by 122
Iqbal, A. K. M., Khan, A. Y., Kalashetti, M. B., Belavagi, N. S., Gong, Y., & Khazi, I. A. M. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.04.015 · Cited by 113
Kishida, K., Shimomura, I., Nishizawa, H., Maeda, N., Kuriyama, H., Kondo, H., Matsuda, M., Nagaretani, H., Ouchi, N., Hotta, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108213200 · Cited by 114
Brown vs white adipocytes: The PPARγ coregulator story
Koppen, A., & Kalkhoven, E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.035 · Cited by 109
“PPARc is a member of the peroxisome proliferator-activated receptor family, of which the firstly identified PPARa was able to respond to various compounds that induce peroxisome proliferation [20].”
BackgroundLocalization of PPARδ in murine central nervous system: expression in oligodendrocytes and neurons
Woods, J. W., Tanen, M., Figueroa, D. J., Biswas, C., Zycband, E., Moller, D. E., Austin, C. P., & Berger, J. P. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02515-0 · Cited by 120
Cherkaoui‐Malki, M., Meyer, K., Wq, C., Latruffe, N., Yeldandi, A. V., Rao, M. S. R., Bradfield, C. A., & Reddy, J. K. (2001) · Gene Expression · doi:10.3727/000000001783992533 · Cited by 123
“Peroxisome proliferator-induced pleiotropic responses are mediated by peroxi- of natural PPARα ligands and the unmetabolized substrates of AOX function as endogenous ligands some proliferator-activated receptor-α (PPARα) (38), a member of the family of ligand-dependent nuclear for PPARα, leading to an enzyme receptor…”
BackgroundRottensteiner, H., Kal, A. J., Filipits, M., Binder, M., Hamilton, B., Tabak, H. F., & Ruis, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00655.x · Cited by 122
“proliferation activation factors) (Issemann and Green, 1990; Dreyer et al., 1992; Gottlicher et al., 1992; Sher et al., 1993; Lee et al., 1995).”
Irukayama‐Tomobe, Y., Miyauchi, T., Sakai, S., Kasuya, Y., Ogata, T., Takanashi, M., Iemitsu, M., SUDO, T., Goto, K., & Yamaguchi, I. (2004) · Circulation · doi:10.1161/01.cir.0000112596.06954.00 · Cited by 112
Receptor-mediated mechanisms of peroxisome proliferators
Green, S. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90554-v · Cited by 112
Self-citationTau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
Mueed, Z., Tandon, P., Maurya, S. K., Deval, R., Kamal, M. A., & Poddar, N. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01017 · Cited by 111
“PPARγ Agonists as Therapeutic Approach in AD The peroxisome proliferator activated receptor (PPAR) is a representative of nuclear receptor family that participates in the adipogenesis (Issemann and Green, 1990).”
BackgroundIto, Y., Kamijima, M., & Nakajima, T. (2019) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-019-0802-z · Cited by 113
Bai, P., Houten, S. M., Huber, A., Schreiber, V., Watanabe, M., Kiss, B., de Murcia, G., Auwerx, J., & Murcia, J. M.-D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701021200 · Cited by 105
Ide, T., Lakshmikuttyamma, A., Takahashi, Y., Kushiro, M., Fukuda, N., & Sugano, M. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00167-6 · Cited by 123
The biochemistry of oleate induction: Transcriptional upregulation and peroxisome proliferation
Gurvitz, A., & Rottensteiner, H. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.011 · Cited by 127
“The key regulator of peroxisome induction and proliferation in mammals is the peroxisome proliferator-activated receptor α (PPARα), a member of the nuclear receptor family [104].”
BackgroundComparative toxicity of fatty acids on a macrophage cell line (J774)
de Lima, T. M., Cury‐Boaventura, M. F., Giannocco, G., Nunes, M. T., & Curi, R. (2006) · Clinical Science · doi:10.1042/cs20060064 · Cited by 118
Auwerx, J. H., Schoonjans, K., Fruchart, J., & Staels, B. (1996) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.3.81 · Cited by 120
Sumanasekera, W. K., Tien, E. S., Turpey, R., Vanden Heuvel, J. P., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211261200 · Cited by 109
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Hong, T., Chen, Y., Li, X., & Lü, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6889533 · Cited by 124
“PPARs are named for their interaction with peroxisome proliferators [145].”
BackgroundPeroxisome Proliferator–induced Pleiotropic Responses: Pursuit of a Phenomenona
Reddy, J. K., & Chu, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18616.x · Cited by 122
Peroxisome proliferator-activated receptors and cardiovascular remodeling
Schiffrin, E. L. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00677.2004 · Cited by 113
“Introduction Peroxisome proliferator-activated receptors (PPARs) are nuclear factors initially shown to respond to xenobiotics with peroxisomal proliferation in the rodent liver [30].”
BackgroundPineau, T., Hudgins, W. R., Liu, L., Chen, L., Sher, T., Gonzalez, F. J., & Samid, D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00340-1 · Cited by 110
Fauconnet, S., Lascombe, I., Chabannes, E., Adessi, G.-L., Desvergne, B., Wahli, W., & Bittard, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200172200 · Cited by 111
Kudo, N., Suzuki-Nakajima, E., Mitsumoto, A., & Kawashima, Y. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1952 · Cited by 109
PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway
Varnat, F., ten Heggeler-Bordier, B., Grisel, P., Boucard, N., Corthesy-Theulaz, I. E., Wahli, W., & Desvergne, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.004 · Cited by 115
Wakino, S., Hayashi, K., Kanda, T., Tatematsu, S., Homma, K., Yoshioka, K., Takamatsu, I., & Saruta, T. (2004) · Circulation Research · doi:10.1161/01.res.0000142313.68389.92 · Cited by 109
Ruan, X. Z., Moorhead, J. F., Fernando, R., Wheeler, D. C., Powis, S. H., & Varghese, Z. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000050414.52908.da · Cited by 109
Melnick, R. L. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109437 · Cited by 109
“The discovery of the peroxisome proliferator activated receptor (PPAR) (27), a ligandactivated transcription factor, provides a mechanistic basis for understanding how peroxisome proliferators modulate gene expression leading to the induction of peroxisomal enzymes.”
BackgroundSCHOONJANS, K., STAELS, B., GRIMALDI, P., & AUWERX, J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18181.x · Cited by 109
Oxidative DNA damage — The effects of certain genotoxic and operationally non-genotoxic carcinogens
Clayson, D. B., Mehta, R., & Iverson, F. (1994) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(94)90010-8 · Cited by 116
Umemoto, T., & Fujiki, Y. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2012.01607.x · Cited by 121
Sun, B., Jia, Y., Hong, J., Sun, Q., Gao, S., Hu, Y., Zhao, N., & Zhao, R. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01189 · Cited by 104
The Nuclear Receptor Field: A Historical Overview and Future Challenges
Mazaira, G. I., Zgajnar, N. R., Lotufo, C. M., Daneri-Becerra, C., Sivils, J. C., Soto, O. B., Cox, M. B., & Galigniana, M. D. (2018) · Nuclear Receptor Research · doi:10.11131/2018/101320 · Cited by 122
“Peroxisome Proliferator-activated receptors (PPARs) were added to the family in the early 1990’s [85, 86].”
BackgroundGene expression profiling in the lung and liver of PFOA-exposed mouse fetuses
Rosen, M. B., Thibodeaux, J. R., Wood, C. R., ZEHR, R. D. J., Schmid, J. E., & Lau, C. S. (2007) · Toxicology · doi:10.1016/j.tox.2007.06.095 · Cited by 114
Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis
Shimizu, K. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2249-7 · Cited by 118
Expression of PPAR and RXR Isoforms in the Developing Rat and Human Term Placentas
Wang, Q., Fujii, H., & Knipp, G. T. (2002) · Placenta · doi:10.1053/plac.2002.0855 · Cited by 122
“different chemicals, including long chain fatty acids, eicossanoids, leukotrienes, hypolipidemic drugs, and antidiabetic agents (Issemann and Green, 1990; Forman, Chen and Evans, 1997; Kliewer et al., 1997; Krey et al., 1997) have been demonstrated to bind and activate PPAR isoforms.”
BackgroundLeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J., Gibson, D. P., Brauninger, R. M., & Isfort, R. J. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00199-9 · Cited by 108
Yamazaki, K., Kuromitsu, J., & Tanaka, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6319 · Cited by 108
New insights into activation of the steroid hormone receptor superfamily
Power, R. F., Conneely, O. M., & O’Malley, B. W. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90099-r · Cited by 117
Deranged Myocardial Fatty Acid Metabolism in Heart Failure
Yamamoto, T., & Sano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020996 · Cited by 112
“The PPAR family is a nuclear receptor that controls FA uptake and β-oxidation [41].”
BackgroundGrowth and Division of Peroxisomes
Schrader, M., & Fahimi, H. D. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)55005-3 · Cited by 128
Nunn, A. V., Bell, J., & Barter, P. (2007) · Nuclear Receptor · doi:10.1186/1478-1336-5-1 · Cited by 108
“Background Peroxisomal proliferating-activated receptors (PPARs) were discovered in 1990 with the cloning of a murine orphan receptor that was activated by peroxisomal proliferating compounds (such as the fibrates), hence their name [1].”
Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors
Berger, J., & Wagner, J. A. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150260007381 · Cited by 108
“Murine PPAR a was the first member of this nuclear receptor subclass to be cloned 4 ; it has since been cloned from humans.”
The Podocyte in Diabetic Kidney Disease
Stitt-Cavanagh, E. M., MacLoed, L., & Kennedy, C. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.133 · Cited by 118
“Belonging to the nuclear receptor superfamily, PPARs were first discovered by Issemann and Green in 1990[103].”
MethodPeroxisome Proliferator-Activated Receptor γ Induces Pancreatic Cancer Cell Apoptosis
Eibl, G., Wente, M. N., Reber, H. A., & Hines, O. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5619 · Cited by 115
Rolf, B., Oudenampsen, E., Börchers, T., Færgeman, N. J., Knudsen, J., LEZIUS, A. G., & Spener, F. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00170-0 · Cited by 107
Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver
Gebel, T., Arand, M., & Oesch, F. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80734-x · Cited by 106
Shin, S., Lee, S., Kwon, J., Moon, S., Lee, S., Lee, C., Cho, K., Ha, N., & Kim, K. (2009) · Immune Network · doi:10.4110/in.2009.9.3.98 · Cited by 111
“ceptor superfamily and has three subtypes named α, δ/β, γ (28).”
The orphan nuclear receptors at their 25-year reunion
Mullican, S. E., DiSpirito, J. R., & Lazar, M. A. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0212 · Cited by 112
“The ‘PPAR’ name followed the discovery that PPARa was activated by clofibrate, a lipid-lowering drug that causes peroxisome proliferation in the rodent liver (Issemann & Green 1990); however, the b/d and g subtypes have not been shown to cause peroximsomal proliferation.”
Hunt, M. C., Nousiainen, S. E. B., Huttunen, M. K., Orii, K. E., Svensson, L. T., & Alexson, S. E. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34317 · Cited by 106
Kömüves, L. G., Hanley, K., Jiang, Y. J., Elias, P. M., Williams, M. L. K., & Feingold, K. R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00296.x · Cited by 110
Savas, Ü., Griffin, K. J., & Johnson, E. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.851 · Cited by 113
“(PPARa) (Issemann and Green, 1990), and the demonstra-”
Ligand-induced Peroxisome Proliferator-activated Receptor α Conformational Change
Dowell, P., Peterson, V. J., Zabriskie, T. M., & Leid, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.2013 · Cited by 104
Lycopene prevents DEHP-induced hepatic oxidative stress damage by crosstalk between AHR–Nrf2 pathway
Zhao, Y. P., Bao, R., Zhu, S., Talukder, M., Cui, J.-G., Zhang, H., Li, X., & Li, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117080 · Cited by 106
Role of Peroxisome Proliferator‐Activated Receptors in Inflammation Control
Youssef, J., & Badr, M. (2004) · BioMed Research International · doi:10.1155/s1110724304308065 · Cited by 103
“A group of nuclear receptors, termed peroxisome proliferator-activated receptors (PPARs), was identified during the last decade [1].”
BackgroundYoshimura, R., Matsuyama, M., Segawa, Y., Hase, T., Mitsuhashi, M., Tsuchida, K., Wada, S., Kawahito, Y., Sano, H., & Nakatani, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.10980 · Cited by 101
PPARs and Microbiota in Skeletal Muscle Health and Wasting
Manickam, R., Duszka, K., & Wahli, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218056 · Cited by 100
Yu, X., & Mertz, J. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9366-9374.1997 · Cited by 110
“The PPARs are members of the nuclear receptor superfamily that play important roles in adipogenesis and lipid metabolism (2, 23).”
BackgroundNonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
Rao, P. P. N., Kabir, S. N., & Mohamed, T. (2010) · Pharmaceuticals · doi:10.3390/ph3051530 · Cited by 101
“It should be noted that pirinixic acid ring template was initially reported as a peroxisome proliferator-activated receptor (PPAR-α) agonist [84,85].”
BackgroundShelby, M. K., & Klaassen, C. D. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010397 · Cited by 104
“PPAR induces expression of CYP4A in response to hypolipidemic drugs, such as clofibrate, and increased fatty acids in liver that occur with fasting or uncontrolled diabetes (Issemann and Green, 1990; Singh, 1997).”
BackgroundHertz, R., Berman, I., Keppler, D., & Bar‐Tana, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00242.x · Cited by 105
Krey, G. D., Keller, H., Mahfoudi, A., Medin, J. A., Ozato, K., Dreyer, C., & Wahli, W. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90058-5 · Cited by 104
A Tailored Therapy for the Metabolic Syndrome
Etgen, G. J., Oldham, B. A., Johnson, W. T., Broderick, C. L., Montrose, C., Brozinick, J. T., Misener, E. A., Bean, J. S., Bensch, W. R., Brooks, D. A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1083 · Cited by 105
“Therefore, a new approach aims to combine the insulin-sensitizing potential of a peroxisome proliferator– activated receptor (PPAR)- agonist, molecular target of the thiazolidinediones (TZDs) (6), with the beneficial lipid-modulating activities of a PPAR- agonist, molecular target of the fibrates (7).”
BackgroundThe Role of PPAR-γ in Allergic Disease
Stark, J. M., Coquet, J. M., & Tibbitt, C. A. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01022-x · Cited by 96
Kömüves, L. G., Hanley, K., Man, M., Elias, P. M., Williams, M. L. K., & Feingold, K. R. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00076.x · Cited by 105
Cancio, I., Ibabe, A., & Cajaraville, M. P. (1999) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(99)00019-5 · Cited by 103
Pulmonary hypertension: the science behind the disease spectrum
Wilkins, M. R. (2012) · European Respiratory Review · doi:10.1183/09059180.00008411 · Cited by 113
Application of the Dakin−West Reaction for the Synthesis of Oxazole-Containing Dual PPARα/γ Agonists
Godfrey, A. G., Brooks, D. A., Hay, L. A., Peters, M., McCarthy, J. R., & Mitchell, D. N. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo026655v · Cited by 113
Hulet, S. W., Heyliger, S. O., Powers, S., & Connor, J. R. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000701)61:1<52::aid-jnr6>3.0.co;2-t · Cited by 82
Kaikaus, R. M., Chan, W. K., Lysenko, N., RAY, R. E., de Montellano, P. R. O., & Bass, N. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98392-4 · Cited by 103
Wan, M., Pan, S., Shan, B., Diao, H., Jin, H., Wang, Z., Wang, W., Han, S., Liu, W., He, J., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02258-1 · Cited by 111
“PPARs are nuclear transcription factors in the steroid hormone receptor family that act as biosensors for lipid metabolism changes [503].”
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.